Submit Manuscript  

Article Details


Report of Adverse Events in Colombia: A Successful Case

[ Vol. 14 , Issue. 1 ]

Author(s):

Ornella Moreno-Mattar*, Rosana Ramírez, Andrés Alvarado, Francisco Sierra and Javier Guzmán   Pages 53 - 56 ( 4 )

Abstract:


Background: The Colombian National Food and Drug Surveillance Institute (INVIMA) is responsible for monitoring the safety and efficacy of medicines circulating the Colombian market.

Discussion: This article summarizes the three key strategies the institution has implemented to strengthen the National Pharmacovigilance Program: improving the interaction and working relationship with regional health authorities, expanding the National Pharmacovigilance Network and implementing the electronic submission of adverse events.

Conclusion: The number of adverse events reported in Colombia increased from 5,447 in 2013 to 95,658 in 2017, reaching a population-based reporting ratio within international standards (563 in 2016).

Keywords:

Adverse events, Colombia, electronic report, pharmacovigilance, INVIMA, regional, nodes.

Affiliation:

National Food and Drug Surveillance Institute (INVIMA), Carrera 10 # 64, 28 Bogota, National Food and Drug Surveillance Institute (INVIMA), Carrera 10 # 64, 28 Bogota, National Food and Drug Surveillance Institute (INVIMA), Carrera 10 # 64, 28 Bogota, National Food and Drug Surveillance Institute (INVIMA), Carrera 10 # 64, 28 Bogota, National Food and Drug Surveillance Institute (INVIMA), Carrera 10 # 64, 28 Bogota

Graphical Abstract:



Read Full-Text article